Cardiology

Benefits of indefinite anticoagulant unclear after first VTE

For patients with a first unprovoked venous thromboembolism (VTE), indefinite anticoagulation prevents some recurrent VTE events but induces additional major bleeding events, according to a study published online June 27 ...

Diseases, Conditions, Syndromes

Study reveals recommended anticoagulant therapy for COVID patients

The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalized with COVID-19, in a study published in the New England Journal of Medicine Evidence ...

page 2 from 23